All AbMole products are for research use only, cannot be used for human consumption.
Cariprazine hydrochloride is a dopamine D3-receptor-preferring partial agonist that exhibits high selectivity and affinity to dopamine D3 and D2(L/S) receptors with pKi 10.07 and 9.16/9.31, respectively.
| Molecular Weight | 463.87 |
| Formula | C21H32Cl2N4O.HCl |
| CAS Number | 1083076-69-0 |
| Solubility (25°C) | DMSO 6 mg/mL Water 2 mg/mL |
| Storage | 4°C, dry, sealed |
[1] No authors listed. Aust Prescr. Cariprazine hydrochloride for schizophrenia
[2] Amber Edinoff, et al. Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults
[3] Renee-Marie Ragguett, et al. Cariprazine for the treatment of bipolar depression: a review
[5] Karly P Garnock-Jones. Cariprazine: A Review in Schizophrenia
| Related Dopamine Receptor Products |
|---|
| Apomorphine hydrochloride hemihydrate
Apomorphine hydrochloride hemihydrate is a dopamine D2 agonist. |
| SV 156
SV 156 is a potent and selective D2 dopamine receptor antagonist, with a Ki of 2.5 nM for hD2. SV 156 has approximately 40-fold binding selectivity for D2 dopamine receptors compared to the D3 receptor subtype. |
| Cyclo(glycyl-L-leucyl)
Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity. |
| Onzigolide
Onzigolide (BIM-23A760), a chimeric dopamine-somatostatin compound, shows potent agonist activity at both DA type 2 (D2R) and SST type 2 (SSTR2) receptors. |
| CVL-871
CVL-871 is a partial agonist at dopamine D1/5 receptors and may be used in dementia-related studies. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
